These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 8502472

  • 1. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ, Kohlhuber F, Mautner J, Polack A, Eick D.
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [Abstract] [Full Text] [Related]

  • 2. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A, Strobl L, Feederle R, Schweizer M, Koch E, Eick D, Wiegand H, Bornkamm GW.
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [Abstract] [Full Text] [Related]

  • 3. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K, Mautner J, Strobl LJ, Wolf DA, Christoph B, Geltinger C, Polack A.
    Oncogene; 1995 Apr 06; 10(7):1393-401. PubMed ID: 7731690
    [Abstract] [Full Text] [Related]

  • 4. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
    Eick D, Polack A, Kofler E, Lenoir GM, Rickinson AB, Bornkamm GW.
    Oncogene; 1990 Sep 06; 5(9):1397-402. PubMed ID: 2216463
    [Abstract] [Full Text] [Related]

  • 5. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A, Mautner J, Geltinger C, Hörtnagel K, Christoph B, Asenbauer H, Klobeck G, Polack A, Bornkamm GW.
    Oncogene; 1999 Mar 04; 18(9):1745-53. PubMed ID: 10208435
    [Abstract] [Full Text] [Related]

  • 6. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
    Apel TW, Mautner J, Polack A, Bornkamm GW, Eick D.
    Oncogene; 1992 Jul 04; 7(7):1267-71. PubMed ID: 1620543
    [Abstract] [Full Text] [Related]

  • 7. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D, Polack A, Kofler E, Bornkamm GW.
    Oncogene; 1988 Oct 04; 3(4):397-403. PubMed ID: 3078949
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II.
    Raschke EE, Albert T, Eick D.
    J Immunol; 1999 Oct 15; 163(8):4375-82. PubMed ID: 10510378
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B.
    EMBO J; 1996 Jan 15; 15(2):375-82. PubMed ID: 8617212
    [Abstract] [Full Text] [Related]

  • 10. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK, Judde JG, Max EE, Magrath IT.
    J Immunol; 1993 Jun 15; 150(12):5418-28. PubMed ID: 8515068
    [Abstract] [Full Text] [Related]

  • 11. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
    Gutsch DE, Marcu KB, Kenney SC.
    Cell Mol Biol (Noisy-le-grand); 1994 Sep 15; 40(6):747-60. PubMed ID: 7812182
    [Abstract] [Full Text] [Related]

  • 12. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
    Rätsch A, Joos S, Kioschis P, Lichter P.
    Exp Cell Res; 2002 Feb 01; 273(1):12-20. PubMed ID: 11795942
    [Abstract] [Full Text] [Related]

  • 13. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
    Mautner J, Behrends U, Hörtnagel K, Brielmeier M, Hammerschmidt W, Strobl L, Bornkamm GW, Polack A.
    Oncogene; 1996 Mar 21; 12(6):1299-307. PubMed ID: 8649832
    [Abstract] [Full Text] [Related]

  • 14. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT, Neckers LM, Schneller HE, Woodruff LS, Magrath IT.
    Cancer Res; 1993 Jan 01; 53(1):127-32. PubMed ID: 8416737
    [Abstract] [Full Text] [Related]

  • 15. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G, Wiman KG.
    Oncogene; 1993 Jun 01; 8(6):1495-500. PubMed ID: 8502475
    [Abstract] [Full Text] [Related]

  • 16. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
    Hu HM, Kanda K, Zhang L, Boxer LM.
    Leukemia; 2007 Apr 01; 21(4):747-53. PubMed ID: 17287852
    [Abstract] [Full Text] [Related]

  • 17. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L, Groudine M.
    Genes Dev; 1994 Sep 15; 8(18):2212-26. PubMed ID: 7958890
    [Abstract] [Full Text] [Related]

  • 18. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
    Polack A, Feederle R, Klobeck G, Hörtnagel K.
    EMBO J; 1993 Oct 15; 12(10):3913-20. PubMed ID: 8404859
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G, Carpaneto EM, Ponzanelli A, Ulivi M, Millo E, Scarfì S, Roncella S, Benatti U, Boffa LC, Ferrarini M.
    Cancer Res; 2003 Oct 01; 63(19):6144-8. PubMed ID: 14559793
    [Abstract] [Full Text] [Related]

  • 20. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F, Strobl LJ, Eick D.
    Oncogene; 1993 Apr 01; 8(4):1099-102. PubMed ID: 8455938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.